Cargando…
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
OBJECTIVES: To describe the profile of patients with ankylosing spondylitis (AS) treated with infliximab in Canadian routine care and to assess the effectiveness and safety of infliximab in real world. SETTING: 46 primary care rheumatology practices across Canada. PARTICIPANTS: 303 biological-naïve...
Autores principales: | Rahman, Proton, Choquette, Denis, Bensen, William G, Khraishi, Majed, Chow, Andrew, Zummer, Michel, Shaikh, Saeed, Sheriff, Maqbool, Dixit, Sanjay, Sholter, Dalton, Psaradellis, Eliofotisti, Sampalis, John S, Letourneau, Vincent, Lehman, Allen J, Nantel, François, Rampakakis, Emmanouil, Otawa, Susan, Shawi, May |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823435/ https://www.ncbi.nlm.nih.gov/pubmed/27048632 http://dx.doi.org/10.1136/bmjopen-2015-009661 |
Ejemplares similares
-
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020) -
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry
por: Rahman, Proton, et al.
Publicado: (2017) -
Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population
por: Haraoui, Boulos, et al.
Publicado: (2015) -
Efficacy of BIO K+ CL1285((®)) in the reduction of antibiotic-associated diarrhea – a placebo controlled double-blind randomized, multi-center study
por: Sampalis, John, et al.
Publicado: (2010) -
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly
por: Sampalis, John S., et al.
Publicado: (2018)